文献速递白血病

氨基酸应激反应基因促进儿童急性淋巴细胞白血病对左旋门冬酰胺酶的耐药

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
PubMed 文献 · Blood Adv · 2022-01-01

研究在左旋门冬酰胺酶(LASP)耐药与敏感的儿童急性淋巴细胞白血病(ALL)细胞系及初诊患者原代白血病样本中定义可重复的LASP反应基因。染色质免疫沉淀测序显示LASP处理后表达改变的基因中45%为ATF4直接靶点,SLC7A11为ATF4直接靶点且其基础表达与原代白血病细胞体外LASP耐药相关。用柳氮磺吡啶化学抑制SLC7A11、基因过表达和部分基因敲除在ALL细胞系中重现LASP耐药或敏感。

要点

  • LASP处理后表达改变基因中45%为ATF4直接靶点,34%含LASP响应性ATF4启动子结合事件。
  • SLC7A11是细胞系和患者样本中的反应基因,也是ATF4直接靶点。
  • SLC7A11是仅2.4%基础表达与LASP体外耐药相关的反应基因之一。

核心结论

  • 评估抗白血病药物治疗后基因表达变化与耐药的相关性很重要,许多反应基因在耐药白血病细胞中基础表达可能无差异。

研究设计与样本

  • 研究在LASP耐药和LASP敏感的ALL细胞系以及初诊患者原代白血病样本中定义可重复的LASP反应基因。
  • 使用染色质免疫沉淀测序(ChIP-seq)在ALL细胞系中定义氨基酸应激反应相关转录因子ATF4的靶基因。
  • 使用柳氮磺吡啶化学抑制SLC7A11、基因过表达和部分基因敲除在ALL细胞系中进行实验。

主要发现

  • LASP处理后表达改变的基因中45%为ATF4转录因子直接靶点,其中34%含LASP响应性ATF4启动子结合事件。
  • SLC7A11在细胞系和患者样本中为反应基因,且为ATF4直接靶点。
  • SLC7A11是仅2.4%基础表达也与原代白血病细胞体外LASP耐药相关的LASP反应基因之一。
  • 柳氮磺吡啶化学抑制SLC7A11、基因过表达和部分基因敲除在ALL细胞系中重现LASP耐药或敏感。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Understanding the genomic and epigenetic mechanisms of drug resistance in pediatric acute lymphoblastic leukemia (ALL) is critical for further improvements in treatment outcomes. The role of transcriptomic response in conferring resistance to l-asparaginase (LASP) is poorly understood beyond asparagine synthetase (ASNS). We defined reproducible LASP response genes in LASP-resistant and LASP-sensitive ALL cell lines as well as primary leukemia samples from newly diagnosed patients. Defining target genes of the amino acid stress response-related transcription factor activating transcription factor 4 (ATF4) in ALL cell lines using chromatin immunoprecipitation sequencing (ChIP-seq) revealed 45% of genes that changed expression after LASP treatment were direct targets of the ATF4 transcription factor, and 34% of these genes harbored LASP-responsive ATF4 promoter binding events. SLC7A11 was found to be a response gene in cell lines and patient samples as well as a direct target of ATF4. SLC7A11 was also one of only 2.4% of LASP response genes with basal level gene expression that also correlated with LASP ex vivo resistance in primary leukemia cells. Experiments using chemical inhibition of SLC7A11 with sulfasalazine, gene overexpression, and partial gene knockout recapitulated LASP resistance or sensitivity in ALL cell lines. These findings show the importance of assessing changes in gene expression following treatment with an antileukemic agent for its association with drug resistance and highlight that many response genes may not differ in their basal expression in drug-resistant leukemia cells.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Ferguson DC, McCorkle JR, Barnett KR, et al. Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. Blood Adv. 2022. PMID: 35671062. doi:10.1182/bloodadvances.2022006965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。